Introduction
Since the first intrauterine transfusion performed in our hospital in 1965, 322 pregnancies have been treated for anti-D isoimmunization with this technique. Intrauterine fetal transfusion since then has been performed under cineradiographic control with but little modification of the procedure described originally in Sir WIL-LIAM LILEY'S report in 1963. In 1980, after a trial period, we routinely started to adopt sonography for transfusional-needle guidance into the fetal peritoneal cavity and for monitoring fetal conditions during therapy [5] . Since the first experience reported by HANS-MANN and LANG in 1972 [11] , the advantages of this procedure have been extensively described [1, 9] , especially as regards its great simplicity and the significant reduction or total alimination of X-rays exposure. A few papers have also reported the possible role of sonography in monitoring fetal conditions [12, 16] . In the present paper we report our experience on 24 fetuses treated by intrauterine transfusion (L U. T.) for severe anemia due to anti-D isoimmunization.
Patients and procedures
During three years, 81 pregnant women affected by anti-D isoimmunization were treated in Curriculum vitae MAURO our Perinatal Department; 24 fetuses (29.8%) underwent intrauterine transfusions. When Coomb's titer was 1/16 or higher, amniotic fluid optical density at 450 nm (AOD-450) was analyzed as early as 21 weeks of gestation. The results were interpreted according to the criteria in use in our Centre since 1970, which have extended LILEY'S original zones to earlier than 28 weeks of gestation [7] . Clinical decisions were based on the absolute value and trend of successive AOD-450 values, assuming a reliable spectral absorption curve and on past obstetrical history. Ultrasonographic fetal monitoring provided further data .
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First and last sonographic examination in the 3 improving cases.
In the third group by contrast, only 3 of the 11 fetuses that were already ascitic or hydropic at the first transfusion underwent any reduction of fluid collection, although two of them still showed a marked hepatosplenomegaly. Their AOD-450 value was among the least severe in their group and treatment was started at 23 weeks for two of them (x = 0.330).
The mean number of transfusions among survivors was 3.3 in non-ascitic and 3.5 in ascitic hydropic fetuses. In 2 cases the procedure failed at the first attempt, but it was successfully repeated 24 hours later. We had only one documented lesion, a small blood say located extraperitoneally in the left flank of the baby, which was drained after birth.
Fetal and neonatal outcomes are reported in table II. No fetal loss occurred after 29 weeks. Three fetal deaths occurred within 24 hours after I. U. T., and can be attributable to the procedure (3.3% of the total number of I. U. T.s performed. However, in a case the AOD value rose from 0.240 to 0.624 in 12 days at 27 weeks; a second transfusion was performed after massive hydrops had developed. A second case was referred late to our hospital. At 27 weeks AOD was 1040 and the fetus was severely hydropic and died in utero after the second transfusion at 28 weeks.
Three neonatal deaths occurred at 29 (marked cardiomegaly), 32 (severe hydrops) and 31 weeks (severe hydrops). The values of hemoglo- bin differed significantly (p < 0.05) between the two groups of non-ascitic and ascitic babies at birth.
The overall proportion of survivors among non-ascitic fetuses was 88% and in ascitic/hydropic fetuses 38%. If we consider as ascitic or hydropic only those fetuses which were in this severe condition at the time of the first transfusion, the relative rates would be 69% and 36% respectively.
Discussion
The transformation of intrauterine fetal transfusion into a relatively simple procedure is the most evident contribution provided by ultra^s ound to the management of anti-D isoimmunized pregnancies. Amniographic techniques have caused 20% fetal mortality per transfusion in the experience of some authors [14] . BOWMAN reported a 16.4 per 100 L U. T.s of fetal traumatic deaths [2] ; whereas HARMAN et al. from the same center but on the basis of a more recent experience report no failures or traumatic deaths [12] . In the present series we observed only 2 failed attempts (3%), 1 traumatic lesion (1.5%) and 3 fetal losses (4.4%) per L U. T. However in two of these cases a severe and acute worsening of the fetal condition had occurred just before the last I. U. T. Between 1974 and 1978, 5.5 per 100 I. U. T.s of fetal traumatic losses [4] attributable to transfusion occurred in 85 patients transfused in utero under X-ray control in our centre (2.3 I. U. T.s per fetus).
Other groups have not observed similar trends in these safety standards. In any case the whole series so far reported is still far from reaching a statistical size [1, 3, 6, 9, 10, 12, 16] [3] . Similarly the survival rate of hydropic fetuses in the two periods improved from 50% to 75%. The Harvard Group [10] observed a positive trend in fetal survival rates from the series published in 1977 to the 35 cases of I. U. T.s under sonographic control reported in 1982. Survivors increased from 7% to 29% in hydropic fetuses and from 53% to 62% in non-hydropic fetuses. In our center the comparison between the 1978 series [9] with results obtained in the 24 fetuses treated since the routine introduction of sonography shows a similar trend in survival rate, rising from 13% to 38% in hydropic fetuses and from 51% to 88% in non-hydropic fetuses. A new dramatic improvement in the treatment of hydropic fetuses before 25 weeks by intravascular fetoscopic transfusion has been recently reported by RODECK and co-workers [15] . In this series they obtained survival rate of 85%. In non hydropic fetuses the data so far presented by this group did non differ much from more traditional approach, i. e. 70%.
In more recent papers and in our own experience ultrasound has played an imortant role in monitoring fetal conditions. In our series 3 fetuses were already severely hydropic and 8 ascitic at the time of the scheduled amniocentesis. These findings suggest that in addition to amniocentesis, Rh-affected fetuses must be monitored by ultrasound at least weekly depending on the severity of clinical history. In this way it would be possible to perform the amniocentesis and I. U. T. earlier in worsening cases. We treated two cases with favorable results from 23 weeks of gestation with only moderate ascites. Similarly good results were obtained by DE VORE [8] in two fetuses in which I. U. T.s were started just after the intial fluid collection in the pericardial sac at 22 and 24 weeks of gestation. This is possible, thanks to the detailed analysis of the fetus provided by sonography. However, in some recent reports the terms ascites and hydrops are used interchangeably. We chose to express the evaluation of the fetal condition as judged by sonography, of ascites developing into hydrops. These gross sonographic parameters we adopted matched the AOD values well. The absolute values and trend of AOD-450 before I. U. T. in the cases which developed ascites after the first I. U. T. are much more similar to those already in this state at first transfusion than to persistently non-hydropic fetuses (p < 0.05). Similarly in the three fetuses in which an improvement was observed after the transfusions, the AOD-450 value was lower than in the other fetuses in their group. However this grading is still far from being an answer to the questions posed by isoimmunization of the fetus. It is likely that larger prospective series and a fresh dynamic approach to fetal hazards such as blood flow studies [13] , provide additional and more sensitive parameters for monitoring and treating this severe fetal disease.
Summary
Twentyfour out of 81 fetuses affected by anti-D isoimmunization underwent ultrasonic guided intrauterine transfusions (2.8 I. U. T.s per fetus). The absolute value and trend of AOD 450 micron value was correlated with the severity of fetal condition as evaluated by ultrasonography following simple semiquantitative grading of ascites (mild, moderate, severe) and diagnosis of hydrops. The evaluation of disease was monitored in this way during transfusion therapy. Transfusion procedures have been ultrasonically guided. When ascites was present a few milliliters of isolytic solution allowed the bubbling effect to be observed. In the case of no ascites we confirmed the needle positioning by a cineradiographic sequence lasting a few seconds. Fetal transfusions were repeated every 10 to 15 days and the amount of packed red cells to be injected was determined according to the week of gestation. Post-transfusion monitoring included ultrasonic reevaluation of fetal parameters and non-stress testing. All fetuses were delivered via cesarean section before the 35th week of gestation. In no case was treatment started after the 31st week. Seventeen fetuses were transfused before the 26th week (71%). In 13 fetuses transfusions were started before ascites had appeared. Only 5 fetuses worsened and the 3 which became hydropic eventually died. The ÄOD-450 value of these 5 cases before therapy had already indicated that they were more severely affected. Survival rate in this group was 69%. Eleven fetuses showed different , \ degrees of ascites or hydrops at the time of the first transfusion. A marked improvement was observed only in the 3 cases in which treatment was started early and/ or with only a mild to moderate ascites. Survival rate in this group was 36%. No fetal loss occurred after 29 weeks. Three fetal deaths occurred within 24 hours after I. U. T. Three neonatal deaths occurred at 29 (marked cardiomegaly), 32 (severe hydrops) and 31 weeks (severe hydrops). The transformation of intrauterine fetal transfusion into a relatively simple procedure is the most evident contribution provided by ultrasound to the management of anti-D immunized pregnancies.
In the present series we observed only 2 (3%) failed attempts, 1 (1.5%) subcutaneous traumatic lesion and 3 (3.3% fetal losses per I. U. T.). Between 1974 and 1978 in our Centre 5.5% of fetal traumatic losses attributable to the transfusion procedure occurred in 85 patients transfused in utero under X-ray control. These results are in fact similar to those reported by different centres. Moreover the proportion of survivors rose in the two series from 13% to 36% in hydropic fetuses and from 51% to 69% in non-hydropic fetuses. In recent papers, as well as in our own experience, ultrasound has played an important role in monitoring fetal conditions. This allows the physician to perform scheduled amniocentesis and I. U. T.s earlier in worsening cases. We chose to express the evaluation of the fetal condition as judged by sonography, of ascites developing into hydrops. These gross sonographic parameters we adopted matched the ÄOD values well. The absolute value and trend of AOD-450 before I. U. T. in the cases which developed ascites after the first I. U. T. are much more similar (p = n. s.) to those already in this state at the time of first transfusion than to persistently non-ascitic fetuses (ü < 0.05). similarly in the ascitic fetuses in the three fetuses in which an improvement was observed after the transfusions, the AOD^450 was lower than in the other fetuses in their group. 
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